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Abstract
Background: Cancer and Alzheimer's disease (AD) are two seemingly distinct diseases and rarely
occur simultaneously in patients. To explore molecular determinants differentiating pathogenic
routes towards AD or cancer, we investigate the role of amyloid β protein (Aβ) on multiple tumor
cell lines that are stably expressing luciferase (human glioblastoma U87; human breast
adenocarcinoma MDA-MB231; and mouse melanoma B16F).
Results: Quantification of the photons emitted from the MDA-MB231 or B16F cells revealed a
significant inhibition of cell proliferation by the conditioning media (CM) derived from amyloid
precursor protein (APP) over-expressing cells. The inhibition of U87 cells was observed only after
the media was conditioned for longer than 2 days with APP over-expressing cells.
Conclusion: Our results suggest that Aβ plays an inhibitory role in tumor cell proliferation; this
effect could depend on the type of tumor cells and amount of Aβ.
Introduction
Cancer and Alzheimer's disease (AD) are the leading
causes of death in the elderly. AD is characterized by pro-
gressive neuronal loss and associated deposition of amy-
loid-β proteins (Aβ) and neurofibril tangles.
Glioblastoma multiforme (GBM) is the most malignant
brain tumor in adults, and is one of the most devastating
forms of cancer arising from dramatic proliferation and
migration of tumor cells. Breast cancer is the second most
fatal cancer in women, and skin cancer is the most com-
mon form of cancer. Like most diseases, the risk of getting
AD or cancer increases with age. AD affects nearly 50% for
those aged 85 years or older [1]. GBM reaches its highest
levels between 65 and 85 years of age [2]. About 7% of
population aged 60–79 has breast cancer, and this dou-
bles when they reach 90 years old. In addition, it is esti-
mated that about 50% people who live to age 65 or older
have skin cancer at least once. A large population of cancer
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patients may not survive long enough to develop AD,
especially in the cases of GBM. Among survivors of breast
cancer or skin cancer, it seems that they rarely develop AD
simultaneously. In addition, cancer occurs less frequently
in AD patients than in the general population [3-5]. While
epidemiologic and genetic studies have so far failed to
prove that AD and cancer are likely to be mutually exclu-
sive, decreased cancer frequency in AD patients would
suggest certain cellular mechanisms may exist to prevent
the co-occurrence of cancer and AD.
Amyloid β protein (Aβ) is generated from amyloid precur-
sor protein (APP). APP is processed by two alternative cel-
lular pathways. α-Secretase is involved in non-
amyloidogenic processing and cleaves APP within the Aβ
domain, whereby release of Aβ is prevented, and soluble
APPsα is secreted. Amyloidogenic processing is driven by
β-secretase, which cleaves APP at the N-terminal site of the
Aβ domain. Both α- and β-secretase cleavages produce C-
terminal stubs (termed C83 and C99, respectively) that
remain inserted in the membrane and are either degraded
or further processed by γ-secretase to produce the p3 frag-
ment or the Aβ peptide, respectively [6,7].
Mounting evidence favors the amyloid cascade hypothesis
that causally links AD pathological process and neuronal
cell death to the aggregation and deposition of Aβ [8]. It
has been reported that Aβ exhibits neurotoxic effect via
multi-processes, and some are thought to involve genera-
tion of reactive oxygen species, alteration of intracellular
calcium homeostasis and mitochondrial function, and
activation of caspases [9]. Small, soluble oligomers of Aβ
have been linked to neuronal toxicity and synaptic failure,
as increased levels of oligomeric Aβ species in the media
of cultured cells impaired hippocampal long-term poten-
tiation [10].
APP processing is ubiquitous, and Aβ is produced by
almost all types of cells. Aβ generation may be a defensive
consequence of an underlying disease mechanism [9].
Ischemia, hypoglycemia and traumatic brain injury, con-
ditions that have been shown to put neurons under meta-
bolic stress, all up regulate APP expression in animal
models and cultured cells [11,12]. They also re-route the
metabolism of APP from the non-amyloidogenic to the
amyloidogenic pathway. Inhibition of mitochondrial
energy metabolism alters the processing of APP to gener-
ate amyloidogenic derivatives [13,14], and oxidative
stress has been shown to increase the generation of Aβ
[15-17]. The increased expression of APP and generation
of Aβ under conditions of energetic stress may therefore
be a response to the oxidative challenge observed in the
brain in AD and following injury. In addition, it has been
reported that APP may be related to the malignant pro-
gression of human astrocytic tumors [18], and it has been
shown that intra-tumoral injection of Aβ potently inhibits
the angiogenesis of human glioblastoma and thus inhib-
its the growth of the tumor [19].
To investigate whether naturally secreted Aβ has any
effects on tumor cell proliferation, we have taken advan-
tage of the APP over-expressing cells that generate high
levels of Aβ. Conditioning media (CM) from APP-express-
ing cells contain all kinds of component of the APP deriv-
atives, including Aβ monomers, oligomers, and soluble
APPsα and APPsβ. For Aβ species, studies with any indi-
vidual form of Aβ are difficult, as the different forms are
always in equilibrium [20].
Here we adopted the bioluminescence imaging (BLI) for
cell proliferation assay. BLI is a new technology in com-
parison to more popular cell proliferation assays, such as
MTT assay [21]. It is highly sensitive for non-invasive
examination of ongoing biological processes in small ani-
mals [22]. BLI is based on the detection of visible light
produced during enzyme mediated oxidation of a sub-
strate when the enzyme is expressed as a reporter. For cell-
based assay, the imaging system can accommodate up to
six 96-well plates in one imaging session, so it provides an
ideal high-throughput screening tool to study cell prolif-
eration provided that the cells express the reporter enzyme
luciferase.
In this study we examined the effects of CM containing Aβ
from APP over-expressing cells on three tumor cell lines,
i.e., human GBM, breast cancer and mouse melanoma
cells. Dynamic BLI cell proliferation assay was applied to
measure the proliferation of these cells that stably express
firefly luciferase. Aβ containing CM were obtained from
Chinese Hamster Ovarian (CHO) and human neuroblas-
toma SH-SY5Y cells expressing wild type APP, and human
embryonic kidney 293 (HEK293) cells expressing familial
AD-linked Swedish mutant APP. We found that tumor cell
proliferation was inhibited after the Aβ enriched CM was
applied. This rapid assay makes it an attractive technique
for high throughput screening for anti-proliferation com-
pounds in the future.
Methods
Cell lines
Three cancer cell lines derived from human glioblastoma
(U87-L), breast cancer (MDA-MB231-L) and mouse
melanoma (B16F-L) that stably express firefly luciferase
were daily monitored by BLI. The U87-L cells were gener-
ated as described previously [23]. The coding sequences
for luciferase and neomycin phosphotransferase were
fused and introduced into a pMMP retrovirus. The B16F-L
cells were derived from murine non brain-metastatic
melanoma tumor cells transduced with a lentiviral con-
struct containing the firefly luciferase gene and the GFPCancer Cell International 2009, 9:15 http://www.cancerci.com/content/9/1/15
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gene [24]. The MDA-MB231-L cells were purchased from
Xenogen (Xenogen Corporation, Alameda, CA). It is
derived from MDA-MB231 human adenocarcinoma cells
by stable transfection of the luciferase gene under the
SV40 promoter.
CHO cells expressing wild type APP (7W), SH-SY5Y cells
expressing wild type APP (SKAPP), HEK293 cells express-
ing human soluble APPsα (hAPPs) and HEK293 express-
ing familial AD-linked Swedish mutant APP (SW293)
have been characterized previously [25-28]. The CHO,
SH-SY5Y and HEK293 cells expressing endogenous APP
were used as controls.
All cells were grown in DMEM (InVitrogen) medium sup-
plemented with 10% fetal bovine serum (Sigma), 2
mmol/L L-glutamine (InVitrogen), 100 units/ml penicil-
lin/streptomycin (InVitrogen), and in a humidified
atmosphere at 37°C in 5% CO2.
Media replacement
The U87-L, MDA-MB231-L, B16F-L cells (500 cells/well)
and the 7W, CHO, SKAPP, SH-SY5Y, SW293, HEK293
and hAPPs, HEK293 cells (1000 cells/well) were seeded in
separate 96 well plates. The CM from 7W, CHO, SKAPP,
SH-SY5Y, SW293, HEK293 and hAPPs, HEK293 cells were
harvested at 36 hr, 60 hr and 84 hr after being planted.
Media from the tumor cells was removed and replaced
with fresh CM. Tumor cells with the CM were monitored
for 24 hr to 72 hr by BLI.
Aβ assay by ELISA
The Aβ levels in CM were measured before media replace-
ment. Aβ sandwich ELISAs were performed as described
[29]. Aβ40 and Aβ42 levels were measured using a standard
sandwich ELISA assay where 2G3 (to Aβ residues 33–40)
and 21F12 (to Aβ residues 33–42) antibodies captured
Aβ40 and Aβ42, respectively, and biotinylated 266 anti-
body was used for detection.
Quantification of the number of viable cells by 
bioluminescence assay
To eliminate the difference in the level of luciferase
expression in each cell line, calibration of photon flux
with respect to actual cell count was performed. MDA-
MB231-L, B16F-L, and U87-L cells in 100 μL media were
seeded into a 96 well plate by serial dilutions from 51,200
cells to 50 cells per well, each repeated with 3 independ-
ent experiments. The plate was imaged using the IVIS 100
system (2 min, 8 bin, and level B/FOV 15 × 15 cm) (Xeno-
gen Corporation, Alameda, CA) at 10 minutes after addi-
tion of luciferin at the final concentration of 150 μg/mL.
Media without luciferin were served as negative control.
The photon flux was linearly regressed on the actual cell
count to obtain a calibration curve for each cell line, as
previously reported [30].
The baseline of the tumor cell proliferation was obtained
by BLI assay 12 hrs after cells were planted. Lights emitted
from tumor cells were acquired until 72 hr post media
replacement with 24 hr interval. An average of 3 kinetic
bioluminescent acquisitions was obtained within 10 min-
utes for each acquisition time point. Regions of interest
(ROI) were drawn over wells automatically and quanti-
fied by Living Image Software version 2.20. Data was ana-
lyzed based on total photon flux emission (photons/s)
subtracted by the background photon flux of each well for
the dark current measurement.
Statistical analysis
SPSS10.0 software was used for the statistical analysis.
Data was obtained from three independent experiments
with duplicate determinations and expressed as means ±
SEM (standard error of the means). Statistical analysis was
performed by one-way ANOVA followed by Fisher's post-
hoc test procedure for significance (P < 0.05).
Results
Stable expression of luciferase in U87-L, MB-231-L and 
B16F-L cells
To quantify the cell proliferation based on the detected
photons from the living cells, we have determined the cor-
relation between the number of U87-L, MDA-MB231-L
and B16F-L cells and the expression levels of luciferase
using BLI assay. Our BLI apparatus reaches a sensitivity of
detecting about 20 MDA-MB231-L cells. Due to different
expression levels of luciferase gene and morphological
appearance of cell types, as low as 80 to 110 of U87-L and
B16F-L cells could be detected by our BLI apparatus.
When cells were seeded at higher density, there was no sat-
uration of signals using the above imaging parameters. A
positive linear correlation between the cell numbers and
the BLI signals was obtained, and all three cell lines have
demonstrated clear correlation, i.e., R2 = 0.9779–0.9984
(Fig. 1). Therefore, it is reliable to quantify the number of
viable cells and cell proliferation based on the photon
emission detected by BLI.
Conditioning media from APP over-expressing CHO cells 
reduced the proliferation of MB-231-L cells
To explore any molecular determinants that differentiate
pathways leading to AD versus cancer, we explore the role
of the key peptide found in the brains of AD patients, Aβ,
which secretes from different types of cells and aggregates
into extracellular neuritic plaques. Instead of using syn-
thetic Aβ peptide, we used naturally secreted Aβ in the
conditioning media (CM) from three types of cells (CHO,
HEK293 and SH-SY5Y) to treat tumor cells and searched
for any inhibitory effect on cell proliferation.
We conditioned APP-over-expressing cells (7W cells) and
its parental cell line CHO cells for 36 hrs, and harvested
Aβ-rich 7W CM and control CHO CM, then applied themCancer Cell International 2009, 9:15 http://www.cancerci.com/content/9/1/15
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to 6 wells of adenocarcinoma MDA-MB231-L cells,
respectively (Fig. 2A, top panel CHO CM, lower panel 7W
CM). The effect of Aβ on tumor cell proliferation was
measured by BLI (Fig. 2A). After incubation for 24 hr, con-
ditioning media from 7W cells significantly delayed
MDA-MB231-L cell proliferation compared to media
from control CHO cells (P < 0.05) (Fig. 2B). When we
continued to incubate tumor cells with CM from CHO or
7W cells for 48 hrs, the number of MDA-MB231-L cells
incubated with CM from 7W cells was significantly lower
than those incubated with control CHO CM (Fig. 2C).
Extended incubation up to 72 hr further decelerated cell
proliferation, resulting in about 50% reduction in the
number of cells grown in 7W CM, compared to those in
CHO CM (Fig. 2C). Together, these results suggested that
CM from 7W cells reduced the proliferation of MDA-
MB231-L cells.
Inhibitory effect was independent of tumor cell types
To determine whether the inhibitory effect of the CM
from 7W cells depends on the type of the tumor cell, we
used a second cancer cell line: melanoma B16F-L. We con-
ditioned 7W and CHO cells for 36 hr. After CM from 7W
or CHO cells were applied to B16F-L cells and incubated
for an extended period, we found a similar, but less dra-
matic effect on cell proliferation, as measured by BLI assay
(Fig. 2D). At 24 hr post media replacement, the number
of B16F-L cells grown in the CM from 7W cells was 50% ±
9% of those grown in CHO control media (Fig. 2D), while
the number of MDA-MB231-L cells grown in the CM of
7W was 69% ± 5% of those grown in CHO CM (Fig. 2C).
At 48 hr post medium replacement, numbers of B16F-L
and MDA-MB231-L cells grown in 7W CM were 59% ±
6% and 59% ± 4% of those with CHO CM, respectively
(Fig. 2C and 2D). The delay in cell proliferation was con-
tinued to 72 hr post medium replacement, when the
number of cells in the presence of 7W CM was about 64%
± 7% and 47% ± 5% of those with CHO CM (Fig. 2C and
2D). Therefore, the CM from APP over-expressing 7W
cells decelerated proliferation of both adenocarcinoma
and melanoma cells, suggesting that the inhibition was
independent of tumor cell types.
Cell media conditioned for extended period had greater 
inhibitory effect on tumor cell proliferation
Since more Aβ is secreted into the CM with longer incuba-
tion time [31], we tested whether the media conditioned
for a longer period would result in greater effect on tumor
cell proliferation. In addition to 36 hr incubation period,
we cultured 7W and CHO cells for 60 hr and 84 hr (con-
ditioning times) then collected CM. Next, we applied the
CM to MDA-MB231-L or B16F-L cells and incubated for
24 hr (incubation time) before acquiring images by BLI
(Fig. 3A). For the MDA-MB231-L cells, the CM condi-
tioned for 60 hr (60 hr-CM) showed stronger inhibitory
effect than the 36 hr-CM (P < 0.05), and the 84 hr-CM
showed the strongest inhibitory effect compared to the 36
hr- and 60 hr-CM (P < 0.05) (Fig. 3A and 3B). For the
B16F-L cells, both 60 hr-CM and 84 hr-CM showed
stronger inhibition compared to 36 hr-CM (P < 0.05), but
no significant difference was observed between the 60 hr-
and 84 hr-CM (Fig. 3C). Taken together, these results indi-
Quantification of MDA-MB231-L, B16F-L and U87-L cell proliferation by bioluminescent imaging (BLI) assay Figure 1
Quantification of MDA-MB231-L, B16F-L and U87-L cell proliferation by bioluminescent imaging (BLI) assay. 
MDA-MB231-L (A), B16F-L (B) and U87-L (C) cells in 100 μL media were seeded into a 96 well plate by serial dilutions from 
51,200 cells to 50 cells per well. The plate was imaged using the IVIS system (2 min, 8 bin, and level B/FOV 15 × 15 cm) at 10 
minutes after the addition of luciferin to final concentration of 150 μg/mL. Medium without luciferin was served as a negative 
control. A linear correlation between cell number and bioluminescent signal was obtained.
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cate that more Aβ accumulated in media conditioned for
an extended period had greater inhibition on prolifera-
tion of tumor cells.
Source of cells for preparing conditioning media was not 
cell type specific
In order to determine whether Aβ from other cell types
had similar effects, media from the APP over-expressing
human neuroblastoma SH-SY5Y cells (SKAPP cells) and
its parental cell line SH-SY5Y were used for the incubation
with tumor cells. After SKAPP and SH-SY5Y cells were
grown for 36 hrs (conditioning time), CM was collected
and applied on tumor cells for 24, 48 and 72 hr, followed
by BLI acquisition. Apparently, there was a delay in cell
proliferation in the presence of CM from SKAPP cells dur-
ing the incubation period from 24 to 72 hrs. While the
number of cells grown in the CM of SKAPP cells was sta-
tistically lower than those in the CM of SH-SY5Y cells, the
difference in the number of MDA-MB231-L cells (Fig. 4A)
was slightly larger than those of B16F-L cells (Fig. 4B).
This is consistent with the previous observation with the
CM from 7W and CHO cells (Fig. 2C and 2D).
Similarly, when we extended the conditioning time to 60
and 84 hrs, we found that CM from SH-SY5Y cells acted
almost identically to the CM from CHO cells. The 60 hr-
and 84 hr-CM from SKAPP cells showed stronger inhibi-
tion effect on cell proliferation of MDA-MB231-L and
B16F-L cells than 36 hr-CM (P < 0.05), but no significant
difference was observed between the media conditioned
for 60 hr and 84 hr (Fig. 4C and 4D). This is highly similar
to B16F-L cells grown in the CM from 7W cells (Fig. 3C).
Soluble APP in conditioned media failed to inhibit cell 
proliferation
The major components secreted from APP over-expressing
cells include Aβ as well as soluble APP (APPsα and
APPsβ). The majority of soluble APP is APPsα, which
derives from α-secretase cleavage of APP; only very low
levels of APPsβ (derived from β-secretase cleavage of APP)
exist in the CM. Therefore, we searched for any inhibitory
effect on tumor cell proliferation by APPsα. Taking advan-
tage of stable HEK293 cell line overexpressing soluble
APPsα, hAPPs, we cultured hAPPs cells and its parental
cell line HEK293. Because the α-secretase cleaves in the
middle of Aβ region, thus precluding the generation of Aβ,
only endogenous levels of Aβ are generated in hAPPs cells,
and levels of Aβ in CM from hAPPs expressing cells were
undetectable by our ELISA (data not shown). When we
conditioned media from hAPPs and HEK293 cells for 36
hr and applied CM to MDA-MB231-L and B16F-L cells for
24, 48 and 72 hrs, no inhibitory effects were observed
(Fig. 5A and 5B). Therefore, high levels of APPsα did not
affect the cell proliferation.
Media from APP over-expressing CHO cells suppress MDA- MB231-L and B16F-L cell proliferation Figure 2
Media from APP over-expressing CHO cells suppress 
MDA-MB231-L and B16F-L cell proliferation. MDA-
MB231-L and B16F-L cells (500 cells/well), APP over-
expressing CHO cells (7W cells) and CHO cells (1000 cells/
well) were seeded in 96 well plates. After 36 hr, media of 
MDA-MB231-L and B16F-L cells were replaced with the 
media from 7W or CHO cells. Proliferation of the MDA-
MB231-L and B16F-L cells was measured by BLI assay at 24 
hr post medium replacement. (A) A representative image 
from MDA-MB231-L cells cultured with conditioning media 
(CM) from CHO cells (CHO-CM) or from 7W cells (7W-
CM) for 24 hr. 7W-CM and control CHO-CM were applied 
to 6 wells of adenocarcinoma MDA-MB231-L cells, respec-
tively (top panel CHO-CM, lower panel 7W-CM). (B) Mean 
values from three independent experiments were obtained, 
and media from 7W cells showed inhibition of MDA-MB231-
L proliferation, compared to media from CHO cells. The 
standard error of means (SEM) was illustrated (n = 12), and 
the asterisk indicates a statistically significant difference 
between two groups (P < 0.05, one-way ANOVA followed 
by Fisher's post-hoc test). (C) Persistent inhibitory effect of 
CM from 7W cells on MDA-MB231-L cell proliferation. The 
proliferation of the MDA-MB231-L cells was measured by 
BLI assay at 24, 48 and 72 hr post medium replacement. The 
photon counts at 24 hr before medium replacement (-24 hr) 
were used as the baseline for the calculation of relative cell 
numbers. All values indicate means ± SEM (n = 6), and signifi-
cant difference between CM from 7W and control CHO 
cells is indicated by * P < 0.05. (D) Inhibitory effect of media 
from APP over-expressing CHO cells on melanoma (B16F-L) 
cell proliferation. B16F-L cells were quantified by BLI assay at 
24, 48 and 72 hr after incubation with CM from 7W or CHO 
cells. All values represent means ± SEM (n = 6), and CM from 
7W cells showed significant difference in it ability to inhibit 
B16F-L cell proliferation compared to CM from control 
CHO cells, as indicated by * P < 0.05.
A
CHO
B
*
0
2
4
6
8
M
e
a
n
 
B
i
o
l
u
m
i
n
e
s
c
e
n
c
e
P
h
o
t
o
n
s
u
1
0
4
/
s
e
c
o
n
d
MDA-MB231-L
1
2
3
4
-24 0 24 48 72
Time post media replacement (hr)
R
e
l
a
t
i
v
e
 
N
u
m
b
e
r
 
o
f
 
C
e
l
l
s
7W
CHO
0
C
-36
cell 
seeding *
* *
MDA-MB231-L
*
*
*
0
3
6
9
12
-24 0 24 48 72
Time post media replacement (hr)
R
e
l
a
t
i
v
e
 
N
u
m
b
e
r
 
o
f
 
C
e
l
l
s CHO
7W
D
cell 
seeding
-36
B16F-L
7W
7W CHO
- AE
+ AE
- AE
+ AECancer Cell International 2009, 9:15 http://www.cancerci.com/content/9/1/15
Page 6 of 12
(page number not for citation purposes)
Inhibitory effect on tumor cell proliferation correlates with 
Aβ concentrations in conditioning media
To validate that Aβ in the CM delayed the proliferation of
these tumor cells, we measured Aβ40 and Aβ42 concen-
trations in the CM from all cell lines. We found that both
7W and SKAPP secreted similar amount of Aβ into the
CM. Therefore, we used a third cell line, a HEK293 cell
line over-expressing familial AD-linked Swedish mutant
APP (SW293). It has been reported that SW293 cells
secrete very high levels of Aβ to the CM [28]. Clearly,
within 36 hr, much more Aβ40 and Aβ42 were secreted
into the CM from SW293 cells than those from 7W and
SKAPP cells (Fig. 6A and 6B), and Aβ levels increased sig-
nificantly upon prolonged conditioning for 60 hr (Fig. 6A
and 6B). The amount of Aβ40 and Aβ42 in the CM from
SW293 cells continued to increase and maintained at high
levels when cells were conditioned to 84 hr, but the levels
of Aβ in the CM from 7W and SKAPP cells started to
decrease when conditioning was extended to 84 hrs (Fig.
6A and 6B), partially due to a potential degradation and/
or aggregation of Aβ peptide, where our ELISA only meas-
ures soluble monomeric Aβ.
Similar to the findings that Aβ40 and Aβ42 concentra-
tions in the CM from the SW293 cells were significantly
higher than those from 7W and SKAPP cells (Fig. 6A, B
and 6C), the inhibitory ability of CM from SW293 cells on
MDA-MB231-L and B16F-L cells was stronger than those
of 7W and SKAPP cell CM. Compared with HEK293 CM
treated cells, the number of MDA-MB231-L and B16F-L
cells were much less after 24 hr incubation in the 36 hr-
CM from SW293 cells (68% ± 2% and 49% ± 4%, respec-
tively). Longer periods of incubation up to 72 hr also
showed reduced cell numbers to 41% ± 3% and 31% ±
3%, respectively (Fig. 6D, E and 6F).
High levels of Aβ were necessary to inhibit the 
proliferation of human neuroblastoma cells (U87-L)
Apparently, both MDA-MB231-L and B16F-L were very
sensitive to Aβ in the CM. Next, we examined a cell line
that seemed to be less sensitive to Aβ in the CM, human
glioblastoma, U87-L. When BLI was used to monitor the
proliferation of U87-L upon the incubation of cells in the
CM from 7W and SKAPP cells, no inhibitory effects were
observed because these cells produced relatively low Aβ
compared to SW293 cells (Fig. 7A and 7B). However, we
found a significant delay in cell proliferation by the
SW293 CM that was conditioned for 60 hr or 84 hr (Fig.
7C). We did not observe much inhibitory effect by the CM
conditioned for 36 hr, consistent with the fact that the
Aβ40 and Aβ42 levels of the 60 hr-CM and 84 hr-CM are
two to five fold greater than that in the 36 hr-CM from
SW293 cells (Fig. 6A and 6B). These results indicate that
inhibitory ability of the CM correlated to the concentra-
tion of Aβ levels.
Surface plots of tumor cell proliferation versus the 
concentration of Aβ40 and Aβ42 in the conditioning media
Finally, we plotted the cell proliferation of the three tumor
cell lines as a function of the Aβ concentration (Fig. 8). We
Media conditioned for extended period with APP over-expressing CHO cells have greater inhibitory effect on tumor cell pro- liferation Figure 3
Media conditioned for extended period with APP over-expressing CHO cells have greater inhibitory effect on 
tumor cell proliferation. MDA-MB231-L cells, B16F-L cells (500 cells/well), 7W and CHO cells (1000 cells/well) were 
seeded in separate 96 well plates. 7W and control CHO cells were grown for 36 hr, 60 hr and 84 hr before the media were 
harvested for incubation with tumor cells. The number of tumor cells was measured by BLI assay at 24 hr post medium 
replacement. (A) A representative image of MDA-MB231-L cells was acquired at 24 hr after the media were replaced with 
media conditioned with CHO or 7W cells for 36, 60 or 80 hr. (B) The relative number of cells grown in CM from 7W vs. 
CHO was calculated by dividing MDA-MB231-L cells grown in 7W-CM by those in CHO-CM. The values represent means ± 
SEM (n = 6), and the difference is statistically significant compared to cells in 36 hr-CM, as indicated by * P < 0.05.
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used a second-order polynomial to approximate the rela-
tionship between the cell proliferation of B16F-L and
Aβ40 concentrations. We sorted the Aβ concentrations in
the ascending order for all the three time points (36 hr, 60
hr, and 84 hr), followed by a second-order polynomial to
fit the corresponding cell proliferation of B16F-L to mini-
mize the least-squares error. Using the derived polyno-
mial, we calculated the cell proliferation of the tumor cell
from a minimum Aβ40 concentration of 26 pM to a max-
imum of 172 pM at a step size of 5 pM. The same proce-
dure was used to perform curve-fitting for MDA-MB231-L
and U87-L cell lines. Finally we used the Matlab® com-
mand "surf" to plot the cell proliferation of the three
tumor cell lines as a function of the Aβ40 concentration
(Fig. 8A). Identical approach was used to plot the cell pro-
liferation versus the Aβ42 concentration (Fig. 8B). While
three tumor cell lines exhibited different cell proliferation
at the same Aβ concentrations, these tumor cells tended to
have reduced cell proliferation as the concentration of Aβ
increased.
Discussion
The inhibitory effects on tumor cell proliferation attribute
to Aβ in the conditioning media of the cells over-express-
ing wild type or Swedish mutant APP. Aβ peptides are
released as soluble products from APP via a series of met-
abolic cleavage steps. After 36 hr of growth, concentra-
APP over-expressing human neuroblastoma SH-SY5Y cells  (SKAPP cells) had the similar inhibitory effects on the tumor  cell proliferation Figure 4
APP over-expressing human neuroblastoma SH-
SY5Y cells (SKAPP cells) had the similar inhibitory 
effects on the tumor cell proliferation. MDA-MB231-L 
cells, B16F-L cells (500 cells/well) and SKAPP, SKNSH cells 
(1000 cells/well) were seeded in separate 96 well plates. The 
number of MDA-MB231-L cells (A) and B16F-L cells (B) was 
measured by BLI assay at 24, 48 and 72 hr after incubation of 
36 hr-CM from SKAPP or SH-SY5Y cells. The media from 
SKAPP cells showed significant difference in their ability to 
inhibit tumor cell proliferation compared to the media from 
control SH-SY5Y cells, as indicated by * P < 0.05. (C and D) 
SKAPP and control SKNSH cells were grown for 36 hr, 60 hr 
and 84 hr for incubation with tumor cells. The number of 
tumor cells was measured by BLI assay after 24 hr of incuba-
tion. The inhibitory effect of media on MDA-MB231-L cells 
(C) and B16F-L cells (D) was stronger than those media from 
shorter period of conditioning. The difference is statistically 
significant, * P < 0.05. All values represent means ± SEM (n = 
6).
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Lack of inhibitory effect on cell proliferation by soluble APP  in CM from hAPPs expressing cells Figure 5
Lack of inhibitory effect on cell proliferation by solu-
ble APP in CM from hAPPs expressing cells. MDA-
MB231-L cells, B16F-L cells (500 cells/well), hAPPs and 
HEK293 cells (1000 cells/well) were seeded in separate 96 
well plates. The number of MDA-MB231-L cells and B16F-L 
cells was measured by BLI assay after incubation of 36 hr-CM 
from hAPPs (A) or HEK293 cells (B). The media from hAPPs 
cells showed no significant difference in their ability to inhibit 
tumor cell proliferation compared to media from control 
HEK293 cells. All values represent means ± SEM (n = 6).
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tions of Aβ in the CM of 7W, SKAPP and SW293 cells were
much higher compared with their corresponding controls,
CHO, SH-SY5Y, and HEK293. The inhibitory effects on
the proliferation of breast and skin cancer cells were
observed upon incubation with the Aβ enriched CM for
24 hrs. It has been shown that various species of Aβ pos-
sess different degrees of cellular toxicity. Soluble Aβ oli-
gomers, including amyloid-derived diffusible ligands
(ADDLs), are more neurotoxic than fibrils and insoluble
larger aggregates [32,33]. A variety of Aβ species carry dif-
ferent physiochemical and pharmacological properties,
and soluble monomers [34], low molecular weight oli-
gomers and ADDLs [10,35], and protofibrils [20,36] are
in equilibrium with insoluble, high molecular weight
fibrils [20]. Aβ42 is known to be more amyloidogenic
than Aβ40. Additional factors, such as pH, ions (Cu2+,
Fe2+, Zn2+) also influence the aggregation process [37-40].
In this study, it is expected that there was Aβ heterogeneity
in aggregation states in the final CM. Our ELISA only
detects soluble monomeric Aβ and cannot quantify the
aggregated Aβ species. Therefore, it is difficult to deter-
mine the exact species that played the dominant inhibi-
tory effects on the tumor cell proliferation. However, it is
well known that synthetic Aβ peptides added in growth
media are notoriously heterogeneous due to variable
preparation conditions, and the status of Aβ peptide
would continuously change during the cancer cell treat-
ment period as they would oligomerize and aggregate.
Inhibitory effect of CM on tumor cell proliferation correlates with Aβ concentrations in the CM Figure 6
Inhibitory effect of CM on tumor cell proliferation correlates with Aβ concentrations in the CM. (A, B) 36 hr-, 60 
hr- and 84 hr-CM from 7W, SKAPP, SW293 and CHO, SH-SY5Y, HEK293 cells were collected, and Aβ40 and Aβ42 concen-
trations were measured by ELISA. Much more Aβ40 (A) and Aβ42 (B) were produced by 7W, SKAPP and SW293 cells than 
their wild type parental cells (P < 0.05). The Aβ40 and Aβ42 concentrations in the SW293-CM were significantly higher than 
those in 7W-CM and SKAPP-CM(P < 0.05). All values represent means ± SEM (n = 12). (C) Relative levels of Aβ generated 
from each cell line were illustrated, based on the actual levels of Aβ (A, B). (D) Representative images from MDA-MB231-L cell 
cultured with 36 hr, 60 hr and 84 hr- CM from 7W/CHO, SKAPP/SH-SY5Y and SW293/HEK293 cells. (E, F) Persistent inhibi-
tory effect of SW293-CM on MDA-MB231-L and B16F-L cells proliferation. The proliferation of the MDA-MB231-L and B16F-
L cells were measured by BLI assay at 24, 48 and 72 hr post medium replacement. All values indicate means ± SEM (n = 6), and 
the difference between SW293 and control HEK293 cells is statistically significant, as indicated by *, P < 0.05.
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Therefore, naturally synthesized, cultured cell derived Aβ
peptides have been used in our experiments, and this
approach has been widely used for Aβ toxicity studies in
AD research [10,41,42].
The CM naturally secreted from APP overexpressing cells
contained substantial amounts of monomeric Aβ and
some oligomeric Aβ. In viewing of the Aβ concentrations
in the CM of 7W, SKAPP and SW293 cells, which showed
a marked increase paralleled with the growth period up to
60 hrs and no further increase up to 84 hrs (except for
Aβ42 from SW293 cells), it is possible that the soluble Aβ
might aggregate into insoluble compositions as more
monomeric Aβ was secreted from the cells during the
extended conditioning period. We found a stronger inhi-
bition of the tumor cells proliferation by the 60 hr-CM,
compared to the effect by the 36 hr-CM. The CM from
SW293 cells had stronger inhibition of the MDA-MB231-
L and B16F-L cells than the 60 hr-CM. Meantime, we
noticed that the media conditioned with three APP over
expressing cells for 36 hrs had a persistent inhibition on
tumor cell proliferation. The inhibitory effects on MDA-
MB231-L and B16F-L cells became more prominent when
the tumor cells were incubated with CM for a longer
period. These Aβ species caused an inhibition of tumor
cell growth at different time points, whereas CM of
untransfected cells had no effect, indicating that both
monomeric and oligomeric Aβ are responsible for the spe-
cific effect.
Since it is still controversial whether Aβ induced toxicity is
cell type dependent [43], we adopted three tumor cell
lines from different sources, the human breast cancer cell
MDA-MB231, GBM cell U87, and mouse melanoma cell
B16F. The MDA-MB231 and B16F cells showed high sen-
sitivities to Aβ in the CM. The cell proliferation of U87,
however, was attenuated only by the media with high
level of Aβ. Although Aβ circulates in peripheral organs
through the whole body, it is equally important to exam-
ine any effect of Aβ containing CM on brain tumor cells
due to the fact that Aβ accumulates extensively in brains
of AD patients. Our results have demonstrated that natu-
rally secreted Aβ from mammalian cells directly inhibit
the proliferation of tumor cells. It is not clear whether any
Aβ receptors at cell surface facilitate the process, as micro-
glia cells have been reported to promote receptor depend-
ent Aβ uptake [44]. Previous studies have shown that G-
protein-coupled formyl peptide receptor like 1 in glial
cells mediates the uptake of its agonist Aβ42, and this
process could be activated by other ligands [45]. For
example, CpG-containing oligodeoxynucleotide, a Toll-
like receptor 9 ligand, increases the expression and activity
of formyl peptide receptor that leads to enhanced endocy-
tosis of Aβ [45]. It is likely that a portion of Aβ in the con-
ditioned media was endocytosed by U87 for subsequent
degradation, which reduced the effect of Aβ on cell prolif-
eration.
Our studies have taken advantage of the cell-based BLI
assay that allows us to rapidly measure cell proliferation
with excellent sensitivity at a high throughput scale.
Although it requires luciferase expressing cell lines to
examine the property of cell colonies, it is a powerful
approach to estimate cell growth with great flexibility,
e.g., it can be used for primary screening of the cytostatic
activity of compounds.
Although our results would suggest that AD patients
might be at lower risk for cancer occurrence, there is no
strategy to overcome the risk of having AD by increasing
Aβ levels in a hope to decrease the chance of cancer forma-
tion. In addition, these findings are obtained from cul-
tured cells in vitro, while the micro-environment for
tumor growth is more complicated in vivo. Therefore, sim-
ply modulating Aβ levels does not seem to be a solution
for inhibiting tumor growth.
Proliferation of human neuroblastoma cells (U87-L) is atten- uated by conditioned media with high Aβ levels Figure 7
Proliferation of human neuroblastoma cells (U87-L) 
is attenuated by conditioned media with high Aβ lev-
els. U87-L cells (500 cells/well) and 7W/CHO, SKAPP/SH-
SY5Y, SW293/HEK293 cells (1000 cells/well) were seeded in 
separate 96 well plates. The U87-L cells were measured by 
BLI assay at 24, 48 and 72 hr after incubation of 36 hr-CM. 
No inhibitory effect was found by the 36 hr-CM from 7W 
cells (A) and SKAPP cells (B). (C) CM were harvested after 
SW293 and HEK293 cells were grown for 36 hr, 60 hr and 
84 hr, The inhibitory effect of 60 hr and 84 hr SW293 CM on 
U87-L cells was stronger than the ability of 36 hr-CM. All val-
ues represent means ± SEM (n = 6), and the difference is sta-
tistically significant, * P < 0.05 compared with 36 hr-CM.
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Nevertheless, understanding the association of Aβ with
tumorigenesis is critical for the elucidation of molecular
pathways related to cell proliferation. The key enzyme for
the generation of Aβ, the γ-secretase, is the target not only
for Alzheimer's disease but also for human T cell acute
lymphoblastic leukemia [46]. While chemotherapy
increases the activity and expression of the γ-secretase
complex, the γ-secretase inhibitor renders colon cancer
cells more sensitive to chemotherapy [47]. Importantly,
the γ-secretase cleavage of APP generates two products, Aβ
and the amyloid intracellular domain (AICD), the latter
to be found as a regulator of EGF receptor at the transcrip-
tion level [48]. EGF receptor is up-regulated in many types
of tumors, therefore, both AICD and EGF receptor are
explored at targets for cancer therapy. Furthermore,
enhanced γ-secretase cleavage of APP leads to increased
generation of APP C-terminal fragments, Aβ and AICD. It
is conceivable that alteration of downstream gene expres-
sion caused by increased APP C-terminal fragments and
AICD may lead to changes in proteins secreted to the con-
ditioned media. Whether those novel factors inhibit cell
proliferation awaits further exploration.
Conclusion
This study provides evidence that naturally secreted Aβ
inhibit the proliferation of cultured GBM, breast cancer,
and skin cancer cells. Understanding the mechanism
underlying the effects of Aβ on tumor cell proliferation
would provide new pathways downstream of Aβ that may
bind to putative tumor cell surface receptors. Identifica-
tion of these pathways will reveal novel targets for thera-
peutic intervention of tumor cell growth.
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Surface plots of tumor cell proliferation versus the concentration of Aβ40 and Aβ42 in the CM Figure 8
Surface plots of tumor cell proliferation versus the concentration of Aβ40 and Aβ42 in the CM. Second-order 
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